Compounds of the formula (I):
in which R, R.sup.1, R.sup.2 and R.sup.3 are as defined in the
description, to their use for the treatment of dyslipidaemia,
atherosclerosis and diabetes, to pharmaceutical compositions comprising
them and to the processes for the preparation of these compounds.